SPECT Imaging of Cardiac Inflammation by Targeting IL4 Receptor-α on Macrophages.

IF 4.5 2区 医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL Molecular Pharmaceutics Pub Date : 2025-05-05 Epub Date: 2025-02-13 DOI:10.1021/acs.molpharmaceut.4c01336
Danzha Zheng, Mengyan Hu, Wenwen Wang, Shan Chen, Zhangyongxue Zhou, Yuhu Lv, Dawei Jiang, Jianjun Chen, Xiaoli Lan, Chunxia Qin
{"title":"SPECT Imaging of Cardiac Inflammation by Targeting IL4 Receptor-α on Macrophages.","authors":"Danzha Zheng, Mengyan Hu, Wenwen Wang, Shan Chen, Zhangyongxue Zhou, Yuhu Lv, Dawei Jiang, Jianjun Chen, Xiaoli Lan, Chunxia Qin","doi":"10.1021/acs.molpharmaceut.4c01336","DOIUrl":null,"url":null,"abstract":"<p><p>The inflammation response is a prominent sign of myocardial infarction (MI), mediating the process of cardiac fibrosis and ventricular remodeling. Inflammation visualization holds new promise for guiding cardiac anti-inflammatory therapy. Interleukin-4 receptor α (IL4Rα) interacts with IL4, closely related to macrophage polarization. This study aimed to evaluate the feasibility of a technetium-99m (<sup>99m</sup>Tc) labeled IL4Rα antibody probe ([<sup>99m</sup>Tc]Tc-HYNIC-CM310) for targeting postinfarction macrophage SPECT imaging. [<sup>99m</sup>Tc]Tc-HYNIC-CM310 was prepared by radiolabeling an IL4Rα-specific monoclonal antibody (CM310) with <sup>99m</sup>Tc. Images were acquired at 0.5, 6, 12, 24, and 36 h postinjection on the next day after MI and the sham model preparation, and a biodistribution study was performed at 36 h. The mean percentage of injected dose per gram (%ID/g) of various tissues was obtained by drawing the regions of interest. [<sup>18</sup>F]FDG myocardial metabolism and inflammation imaging were performed for comparison and verification. Immunofluorescence costaining and flow cytometry were conducted to validate the coexpression of IL4Rα and macrophages. The radiolabeling yield of [<sup>99m</sup>Tc]Tc-HYNIC-CM310 was approximately 88.31% ± 1.70%, and the radiochemical purity was 93.70% ± 0.38%. The accumulation of [<sup>99m</sup>Tc]Tc-HYNIC-CM310 in infarcted myocardium was increased starting at 12 h postinjection. The tracer uptake was significantly higher in the infarcted myocardium than the same site in sham-operated rats (<i>P</i> < 0.05). The tracer uptake region was consistent with the cardiac metabolic defect and inflammatory region seen by [<sup>18</sup>F]FDG PET. Immunofluorescence staining and flow cytometry confirmed the colocalization of IL4Rα<sup>+</sup> cells and macrophage markers in the infarcted myocardium. We successfully prepared and validated the SPECT probe [<sup>99m</sup>Tc]Tc-HYNIC-CM310 for precise visualization of macrophages, offering a new opportunity for guiding the treatment of cardiac inflammation.</p>","PeriodicalId":52,"journal":{"name":"Molecular Pharmaceutics","volume":" ","pages":"2509-2520"},"PeriodicalIF":4.5000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acs.molpharmaceut.4c01336","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/13 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

The inflammation response is a prominent sign of myocardial infarction (MI), mediating the process of cardiac fibrosis and ventricular remodeling. Inflammation visualization holds new promise for guiding cardiac anti-inflammatory therapy. Interleukin-4 receptor α (IL4Rα) interacts with IL4, closely related to macrophage polarization. This study aimed to evaluate the feasibility of a technetium-99m (99mTc) labeled IL4Rα antibody probe ([99mTc]Tc-HYNIC-CM310) for targeting postinfarction macrophage SPECT imaging. [99mTc]Tc-HYNIC-CM310 was prepared by radiolabeling an IL4Rα-specific monoclonal antibody (CM310) with 99mTc. Images were acquired at 0.5, 6, 12, 24, and 36 h postinjection on the next day after MI and the sham model preparation, and a biodistribution study was performed at 36 h. The mean percentage of injected dose per gram (%ID/g) of various tissues was obtained by drawing the regions of interest. [18F]FDG myocardial metabolism and inflammation imaging were performed for comparison and verification. Immunofluorescence costaining and flow cytometry were conducted to validate the coexpression of IL4Rα and macrophages. The radiolabeling yield of [99mTc]Tc-HYNIC-CM310 was approximately 88.31% ± 1.70%, and the radiochemical purity was 93.70% ± 0.38%. The accumulation of [99mTc]Tc-HYNIC-CM310 in infarcted myocardium was increased starting at 12 h postinjection. The tracer uptake was significantly higher in the infarcted myocardium than the same site in sham-operated rats (P < 0.05). The tracer uptake region was consistent with the cardiac metabolic defect and inflammatory region seen by [18F]FDG PET. Immunofluorescence staining and flow cytometry confirmed the colocalization of IL4Rα+ cells and macrophage markers in the infarcted myocardium. We successfully prepared and validated the SPECT probe [99mTc]Tc-HYNIC-CM310 for precise visualization of macrophages, offering a new opportunity for guiding the treatment of cardiac inflammation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
巨噬细胞il - 4受体-α靶向心脏炎症的SPECT成像。
炎症反应是心肌梗死(MI)的显著标志,介导心肌纤维化和心室重构过程。炎症可视化为指导心脏抗炎治疗带来了新的希望。白细胞介素-4受体α (Interleukin-4 receptor α, IL4Rα)与il -4相互作用,与巨噬细胞极化密切相关。本研究旨在评估一种锝-99m (99mTc)标记的IL4Rα抗体探针([99mTc]Tc-HYNIC-CM310)用于梗死后巨噬细胞SPECT成像的可行性。[99mTc]用99mTc放射标记il4r α特异性单克隆抗体(CM310)制备Tc-HYNIC-CM310。在心肌梗死和假模型制备后的第二天,分别于注射后0.5、6、12、24和36小时获取图像,并在36小时进行生物分布研究。通过绘制感兴趣的区域,获得各种组织的每克注射剂量的平均百分比(%ID/g)。[18F]FDG心肌代谢和炎症成像进行比较和验证。通过免疫荧光染色和流式细胞术验证IL4Rα与巨噬细胞的共表达。[99mTc]Tc-HYNIC-CM310的放射标记率约为88.31%±1.70%,放射化学纯度为93.70%±0.38%。注射后12 h梗死心肌中[99mTc]Tc-HYNIC-CM310的积累增加。梗死心肌示踪剂摄取明显高于假手术大鼠同一部位(P < 0.05)。示踪剂摄取区与[18F]FDG PET观察到的心脏代谢缺陷和炎症区一致。免疫荧光染色和流式细胞术证实了IL4Rα+细胞和巨噬细胞标记物在梗死心肌中的共定位。我们成功制备并验证了用于巨噬细胞精确可视化的SPECT探针[99mTc]Tc-HYNIC-CM310,为指导心脏炎症的治疗提供了新的机会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
文献相关原料
公司名称
产品信息
索莱宝
DAPI
来源期刊
Molecular Pharmaceutics
Molecular Pharmaceutics 医学-药学
CiteScore
8.00
自引率
6.10%
发文量
391
审稿时长
2 months
期刊介绍: Molecular Pharmaceutics publishes the results of original research that contributes significantly to the molecular mechanistic understanding of drug delivery and drug delivery systems. The journal encourages contributions describing research at the interface of drug discovery and drug development. Scientific areas within the scope of the journal include physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science as they relate to drug and drug delivery system efficacy. Mechanistic Drug Delivery and Drug Targeting research on modulating activity and efficacy of a drug or drug product is within the scope of Molecular Pharmaceutics. Theoretical and experimental peer-reviewed research articles, communications, reviews, and perspectives are welcomed.
期刊最新文献
Encapsulation of Glucose Oxidase in Porous Cu(II)-Doped Zinc Phosphate@polydopamine Nanoparticles for Triple-Combination Therapy of Cancer. Issue Editorial Masthead Issue Publication Information Voices in Molecular Pharmaceutics: Meet Dr. Kristian Beran, a Pharmaceutical Scientist Bridging Science and Business Voices in Molecular Pharmaceutics: Meet Dr. Yutaka Maeda, Who Pioneers New Therapies to Treat Lung Disease
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1